|
BTC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.65787433465448E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.31039995415949E-09 |
| Normal-vs-Stage2 |
1.5803199999942E-05 |
| Normal-vs-Stage3 |
2.23400000054497E-07 |
| Normal-vs-Stage4 |
5.228100E-04 |
| Stage1-vs-Stage2 |
9.882800E-01 |
| Stage1-vs-Stage3 |
9.934000E-01 |
| Stage1-vs-Stage4 |
8.170600E-01 |
| Stage2-vs-Stage3 |
9.827000E-01 |
| Stage2-vs-Stage4 |
8.387000E-01 |
| Stage3-vs-Stage4 |
7.985800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.67497135553185E-12 |
| Normal-vs-AfricanAmerican |
3.6058000000283E-06 |
| Normal-vs-Asian |
5.374000E-04 |
| Caucasian-vs-AfricanAmerican |
1.370170E-01 |
| Caucasian-vs-Asian |
5.585400E-01 |
| AfricanAmerican-vs-Asian |
3.494600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
2.598000E-04 |
| Male-vs-Female |
5.162100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.13269999999444E-05 |
| Normal-vs-Extreme_Weight |
3.32750493825529E-11 |
| Normal-vs-Obese |
7.75880470982315E-11 |
| Normal-vs-Extreme_Obese |
1.860480E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.192200E-01 |
| Normal_Weight-vs-Obese |
5.234000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.205600E-01 |
| Extreme_Weight-vs-Obese |
3.527600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.951800E-01 |
| Obese-vs-Extreme_Obese |
9.311200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.224400E-04 |
| Normal-vs-Age(41-60Yrs) |
1.25879999757217E-08 |
| Normal-vs-Age(61-80Yrs) |
8.67328431297665E-12 |
| Normal-vs-Age(81-100Yrs) |
1.92710999999957E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.770200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.565800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.936200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.067400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.953800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.687200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.355760114232E-12 |
| Normal-VS-Type2 PRCC |
6.71359967618912E-10 |
| Normal-VS-KIRP CIMP |
8.175600E-02 |
| Normal-VS-Unclassified PRCC |
2.0536000000515E-07 |
| Type1 PRCC-VS-Type2 PRCC |
5.979400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.264000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.895200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.857350E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.334800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.375800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.43809450195931E-11 |
| Normal-vs-N1 |
1.42800000002552E-06 |
| Normal-vs-N2 |
7.208300E-02 |
| N0-vs-N1 |
5.812000E-02 |
| N0-vs-N2 |
5.766400E-01 |
| N1-vs-N2 |
8.201600E-01 |
|
|
